Playback speed
10 seconds
SABCS 2023 Insights: "ctDNA Monitoring of ER+/HER2- High Risk Breast Cancer During Adjuvant Endocrine Therapy"
By
Insights from 2023 SABCS
FEATURING
Lajos Pusztai
By
Insights from 2023 SABCS
FEATURING
Lajos Pusztai
1,626 views
January 2, 2024
Comments 0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY